Researcher.Life Logo

Dose-Response : Impact Factor & More

eISSN: 1559-3258pISSN: 1559-3258
JournalOpen Access

Key Metrics

CiteScore
3.5
Impact Factor
< 5
SJR
Q3Toxicology
SNIP
0.74
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Dose-Response

Dose-Response Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher SAGE PUBLICATIONS INC
Language English
Frequency Quarterly
Article Processing ChargesUSD 2000
Publication Time15
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year2006
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 15
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Dose-Response ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Dose-Response

Comparison of the Efficacy of Different Doses of Filgotinib in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis Based on the RCTs
  • 2 Apr 2026
  • Dose-Response
Retraction: Vitamin C and Turmeric Attenuate Bax and Bcl-2 Proteins’ Expressions and DNA Damage in Lead Acetate-Induced Liver Injury
  • 1 Apr 2026
  • Dose-Response
Retraction: Quercetin and Idebenone Ameliorate Oxidative Stress, Inflammation, DNA Damage, and Apoptosis Induced by Titanium Dioxide Nanoparticles in Rat Liver
  • 1 Apr 2026
  • Dose-Response
Understanding the Radiation Adaptive Response: General Methodology and Theoretical Approaches to the Study of the Radioadaptation Phenomenon
  • 1 Apr 2026
  • Dose-Response
Integrating Adaptive Responses Into Hormesis: δ Plot Analysis of the Yonezawa Effect in the Micronucleus Test.
  • 1 Apr 2026
  • Dose-response : a publication of International Hormesis Society
4,8-Dicarboxyl-8,9-Iridoid-1-Glycoside Alleviates Cardiac Dysfunction After Myocardial Ischaemia-Reperfusion Injury by Activating the PI3K/AKT Pathway.
  • 1 Apr 2026
  • Dose-response : a publication of International Hormesis Society
Comparison of the Efficacy of Different Doses of Filgotinib in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis Based on the RCTs
  • 2 Apr 2026
  • Dose-Response
Retraction: Vitamin C and Turmeric Attenuate Bax and Bcl-2 Proteins’ Expressions and DNA Damage in Lead Acetate-Induced Liver Injury
  • 1 Apr 2026
  • Dose-Response
Retraction: Quercetin and Idebenone Ameliorate Oxidative Stress, Inflammation, DNA Damage, and Apoptosis Induced by Titanium Dioxide Nanoparticles in Rat Liver
  • 1 Apr 2026
  • Dose-Response
Understanding the Radiation Adaptive Response: General Methodology and Theoretical Approaches to the Study of the Radioadaptation Phenomenon
  • 1 Apr 2026
  • Dose-Response
Integrating Adaptive Responses Into Hormesis: δ Plot Analysis of the Yonezawa Effect in the Micronucleus Test.
  • 1 Apr 2026
  • Dose-response : a publication of International Hormesis Society
4,8-Dicarboxyl-8,9-Iridoid-1-Glycoside Alleviates Cardiac Dysfunction After Myocardial Ischaemia-Reperfusion Injury by Activating the PI3K/AKT Pathway.
  • 1 Apr 2026
  • Dose-response : a publication of International Hormesis Society

FAQs on Dose-Response